The purpose of the present study was to clarify the central nervous system function of amino acids during acute stress. In Experiment 1, changes in free amino acid pattern were investigated in the brain of neonatal chicks exposed to either restraint with isolation-induced or fasting stress. L-proline and L-arginine were decreased in the telencephalon and diencephalon under any stress. Since the central nervous system functions of L-arginine during the stress response has recently been reported, in Experiment 2, the effect of intracerebroventricular injection of L-proline (0.5, 1.0, 2.0 micromol) during isolation-induced stress was investigated. L-proline induced sedative and hypnotic effects in a dose-dependent manner. It is suggested that L: -proline may have an important role to attenuate the stress response in the central nervous system of chicks.
The central effects of L-proline, D-proline and trans-4-hydroxy-L-proline were investigated by using the acute stressful model with neonatal chicks in Experiment 1. Sedative and hypnotic effects were induced by all compounds, while plasma corticosterone release under isolation stress was only attenuated by L-proline. To clarify the mechanism by which L-proline and D-proline induce sedative and hypnotic effects, the contribution of the strychnine-sensitive glycine receptor (glycine receptor) and N-methyl-D-aspartate glutamate receptor (NMDA receptor) were further investigated. In Experiments 2-3, the glycine receptor antagonist strychnine was co-injected intracerebroventricular (i.c.v.) with L-proline or D-proline. The suppression of isolation-induced stress behavior by D-proline was attenuated by strychnine. However, the suppression of stress behavior by L-proline was not attenuated. In Experiment 4, the NMDA receptor antagonist (+)-MK-801 was co-injected i.c.v. with L-proline. The suppression of stress behavior by L-proline was attenuated by (+)-MK-801. These results indicate that L-proline and D-proline differentially induce sedative and hypnotic effects through NMDA and glycine receptors, respectively.
In order to determine if orexins affect arousal in neonatal chicks, we intracerebroventricularly (ICV) injected either orexin-A or orexin-B to layer and broiler type chicks (Gallus gallus) and measured their behaviors and food intake following injection. Layer chicks treated with orexin-A at 0.2 and 2.0 nmol had increased arousal but their food intake was not affected. However, arousal was not affected in broiler chicks treated with orexin-A, but they spent less time feeding. When orexin-B was administered to layer and broiler chicks, neither had altered arousal and their food intake was not affected. Therefore, the orexin peptides may differentially affect arousal in the two stocks tested; orexin-A causes a stock dependant increase whereas orexin-B does not affect either.
To clarify whether L-ornithine and/or its metabolite involves sedative and hypnotic effects under social separation stress, the effects of intracerebroventricular (i.c.v.) injection of L-ornithine and polyamines (putrescine, spermidine and spermine) were compared in chicks. Birds were injected i.c.v. with 0.5 mumol of L-ornithine, putrescine, spermidine, spermine or saline (control). After injection, chicks were immediately separated from the flock and monitored for the number of distress vocalizations and various postures. L-Ornithine greatly attenuated the stress response and caused sedative and hypnotic effects. Among the polyamines, only putrescine attenuated distress vocalizations but did not induce sleep. In conclusion, the sedative and hypnotic effect of L-ornithine was mainly induced by L-ornithine itself, while the polyamines contributed to the sedative, but not hypnotic, effect under social separation stress.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.